NAD+ Injections: Benefits, Side Effects, Cost & Evidence (2026)

A quick disclosure: YourHealthier sells an oral NMN supplement, not injectable NAD+. Our recommendation to start oral has a commercial basis — but it also has an evidence basis: 20+ combined RCTs for oral vs zero for injections. We'll present both sides honestly.

NAD+ injections deliver nicotinamide adenine dinucleotide directly via subcutaneous shots, bypassing digestive absorption (unlike oral NMN and NR). They cost $50–$150 per session. But as of mid-2026, zero randomized controlled trials have been published on their efficacy or safety.

Key Takeaways

NAD+ injections deliver NAD+ subcutaneously, bypassing digestion for higher bioavailability. Zero randomized controlled trials have been published on NAD+ injection efficacy or safety as of mid-2026. Cost is $50–$150 per injection ($200–$900/month), versus $30–$60/month for oral NMN. Reported side effects include injection-site pain, flushing, and nausea, but the full risk profile is unmeasured. Oral NMN and NR have 20+ combined RCTs at a fraction of the cost — the evidence favors starting there.

🩺 Doctor's Clinical Note

Dr. Jill Palko, MD, FACOG Cleveland Clinic-Trained · Board-Certified OB/GYN NPI #1093033011 · View Credentials

"There is no current research showing IV NAD+ is superior to oral and IV therapy can potentially be riskier."

What Are NAD+ Injections?

NAD+ injections are subcutaneous or intramuscular shots of nicotinamide adenine dinucleotide, typically 100–500 mg per dose, delivered directly into tissue to bypass digestive absorption. They are not FDA-approved for any condition and have zero published RCTs.

NAD+ injections (also called NAD+ shots or a NAD+ shot) are subcutaneous or intramuscular shots of nicotinamide adenine dinucleotide, typically self-administered at home or given in a clinical setting.

Unlike oral NAD+ precursors (NMN, NR) that your body converts into NAD+ through enzymatic pathways, injections deliver the NAD+ molecule directly into tissue. The theoretical advantage: bypassing the GI tract eliminates absorption variability and first-pass liver metabolism. Shin-ichiro Imai, MD, PhD at Washington University has characterized the NAD+ biosynthetic pathway extensively, noting that direct delivery bypasses the rate-limiting enzymatic steps that oral precursors require.

NAD+ injections aren't FDA-approved for any medical condition. They're sold as compounded preparations through wellness clinics, telehealth platforms, and some pharmacies. The regulatory status is gray: compounding pharmacies can legally prepare NAD+ formulations under physician prescription, but there is no FDA-evaluated manufacturing standard specific to NAD+ injectables.

NAD+ Peptide Injections: What They Are

"NAD+ peptide injection" is a marketing term, not a distinct product. NAD+ is a dinucleotide, not a peptide. Clinics group NAD+ with peptide therapies on their menus, but what you receive is standard injectable NAD+.

"NAD+ peptide injection" is a common search, but the term is technically imprecise. NAD+ is a dinucleotide coenzyme, not a peptide (a peptide is a short chain of amino acids). The confusion arises because wellness clinics frequently market NAD+ injections alongside genuine peptide therapies like BPC-157 or CJC-1295, and the two get grouped together under "peptide injection" menus.

Functionally, a "NAD+ peptide injection" is simply a standard NAD+ injection — subcutaneous nicotinamide adenine dinucleotide, typically 100–500 mg per dose. The benefits claimed for NAD+ peptide injections are identical to those claimed for regular NAD+ injections: direct NAD+ delivery bypassing digestion. And the evidence limitation is identical too: zero randomized controlled trials. If a clinic offers a "NAD+ peptide injection," you're getting NAD+, not a novel peptide compound — the naming is marketing convention, not chemistry.

NAD+ Injections vs Oral Supplements: Which Works Better?

Oral NMN/NR is better supported for most people: 20+ RCTs, low cost, and proven NAD+ elevation. Injections bypass digestion for higher bioavailability, but have zero published RCTs and cost far more. Unless you have a documented absorption problem, oral precursors deliver the same NAD+ increase with vastly more evidence behind them.

Oral NMN and NR have 12+ and 10+ published RCTs respectively. NAD+ injections have zero. The evidence gap is the most important thing to understand.

Eric Verdin, MD, President of the Buck Institute, has emphasized that higher bioavailability does not necessarily translate to better clinical outcomes. What matters is whether NAD+ reaches the right tissues at the right concentrations, and injections haven't been shown to achieve this more effectively than oral precursors.

Charles Brenner, PhD at City of Hope has been more direct: without controlled trial data, NAD+ injection claims rest entirely on theoretical pharmacokinetics and patient anecdotes, neither of which constitutes clinical evidence. For the complete oral precursor comparison including product recommendations, see our NAD+ supplement guide.

What Are NAD+ Injections Used For?

Clinics market NAD+ injections for energy, mental clarity, anti-aging, athletic recovery, and addiction support. Important caveat: none of these uses is backed by published randomized trials. The injections reliably raise NAD+ levels, but whether that produces the marketed benefits is unproven — most reported effects are indistinguishable from placebo without controlled studies.

NAD injections benefits — NAD injection benefits (NAD+ injection benefits) — are primarily theoretical, based on the pharmacological rationale of direct NAD+ delivery rather than clinical trial evidence. The claimed benefits of NAD+ injections (also referred to as NAD+ shot benefits) include the following:

Clinics market NAD+ injections for energy, anti-aging, addiction recovery, cognitive enhancement, and athletic performance. The evidence for each ranges from preliminary to nonexistent.

Energy and fatigue: NAD+ is central to mitochondrial energy production, the same mechanism behind oral NMN's energy effects, so the logic is straightforward. However, the fatigue-reduction data comes from oral NMN trials, not injection studies.

Anti-aging: NAD+ decline is associated with aging (Massudi et al., 2012, PLoS One). Whether restoring levels reverses aging markers in humans remains unproven regardless of delivery method.

Addiction recovery: Some clinics promote NAD+ IV and injections for substance abuse recovery. A 2019 pilot study (Mestayer et al.) documented measurable changes in plasma and urine NAD+ during infusion protocols in people with substance use disorders, but it was a small, uncontrolled pharmacokinetic study — not evidence of clinical efficacy. Not evidence of efficacy. Joseph Baur, PhD at the University of Pennsylvania has noted that the mechanistic rationale for NAD+ in addiction is plausible but entirely preclinical.

Cognitive function: NAD+ supports neuronal health through sirtuin-mediated pathways. Human data is limited to one oral NMN trial showing subjective sleep improvement. No injection-specific cognitive data exists.

What Are the Side Effects of NAD+ Injections?

The most common side effects are injection-site pain, redness, flushing, and nausea — compare with oral NMN side effects — usually mild and short-lived. Because injections have no controlled safety trials, the full risk profile is unmeasured. Compounded injectable NAD+ also carries the sterility risks of any injection prepared outside FDA drug-manufacturing standards.

Because NAD+ injections lack controlled safety trials, the side-effect profile comes from clinical reports and patient accounts rather than systematic data. The most commonly reported NAD+ injection side effects include:

• Injection-site reactions. Pain, redness, swelling, or bruising at the injection site, common with any subcutaneous injection and usually mild.
• Flushing and warmth. A sensation of heat or flushing, particularly if the injection is given too quickly. Slowing administration typically reduces this.
• Nausea. Some people report transient nausea, again linked to injection speed.
• Chest tightness or pressure. A sensation reported during rapid NAD+ administration, which resolves when the rate is slowed.
• Lightheadedness or fatigue. Occasionally reported after injection.

The critical caveat: without controlled trials, the full risk profile of NAD+ injections — including any rare or long-term effects — remains unmeasured. This is a meaningful difference from oral NMN and NR, whose safety has been assessed across multiple randomized trials. Anyone with a heart condition, on medication, or pregnant should consult a physician before considering NAD+ injections.

How Much NAD+ Should You Inject, and How Often?

Clinics typically use 100–500 mg per subcutaneous injection, starting with a loading phase of 2–3 injections weekly, then dropping to 1–2 weekly for maintenance. These protocols are based on clinic practice, not clinical trials — there is no evidence-based standard dose or frequency for injectable NAD+.

Typical protocols use 100–500 mg per injection, 1–3 times per week. These aren't evidence-based doses. They're clinic-derived protocols without clinical trial validation.

Mihoko Yoshino, MD at Washington University achieved clinically significant insulin sensitivity improvements with just 250 mg/day of oral NMN over 10 weeks. Without head-to-head data comparing oral vs injection routes, there's no evidence that injectable NAD+ at these doses produces superior outcomes to oral precursors at studied doses at a fraction of the cost.

How Do You Inject NAD+ Subcutaneously?

Subcutaneous NAD+ is injected into fatty tissue (abdomen or thigh) using an insulin syringe, after cleaning the site with alcohol. It should be done slowly, since rapid injection increases flushing and nausea. This requires a physician's prescription and proper sterile technique — self-injection without clinical guidance carries real infection risk.

NAD+ injections are most commonly administered subcutaneously (into the fat layer under the skin) rather than intramuscularly, because subcutaneous delivery releases NAD+ more slowly and reduces the flushing and discomfort associated with rapid administration. For those prescribed at-home NAD+ injections, clinics typically instruct the following, though this should only be done under medical supervision:

• Injection sites. The abdomen (two inches from the navel) and the outer thigh are the most common subcutaneous sites, rotated to avoid tissue irritation.
• Technique. A short insulin-style needle is inserted at a 45–90 degree angle into a pinched fold of skin.
• Injection speed. NAD+ is injected slowly. Rapid administration is the main trigger for the flushing, nausea, and chest tightness reported with NAD+.
• Dosage. Home protocols commonly range from 50–200 mg per injection, but there is no trial-validated optimal dose.

The lack of standardized, evidence-based protocols is itself a caution flag. Because no controlled trials have established safe and effective NAD+ injection parameters, dosing and frequency vary widely between clinics and rest on practitioner preference rather than data.

NAD+ Injections Before and After: What Should You Expect?

Most users report a subtle energy and clarity boost within the first week, described as 'noticeable but not dramatic.' Effects typically plateau after the loading phase. There are no before-and-after outcomes documented in controlled research — all reported changes come from clinic testimonials and self-reports, which can't be separated from placebo.

Subjective reports include improved energy within hours to days. But without controlled trials, it's impossible to separate genuine NAD+ effects from placebo response.

The placebo effect in injection-based treatments is well-documented and substantial. The physical act of injection, the clinical setting, and the cost all amplify perceived benefit. This does not mean NAD+ injections don't work; it means we cannot know from anecdotes alone. For evidence-based before-and-after timelines from controlled NMN trials, see our NMN before and after guide.

Choosing the Best NAD+ Injections

If you've decided to try NAD+ injections despite the evidence limitations, the best NAD+ injections come from compounding pharmacies that provide certificates of analysis for purity and sterility. Look for USP <797> compliance (sterile compounding standards) and third-party potency testing. Avoid clinics that cannot provide documentation of their NAD+ sourcing.

Who Should Avoid NAD+ Injections?

People with active or prior cancer should consult an oncologist first, since NAD+ fuels all cells. Pregnant or breastfeeding women should avoid injectable NAD+ entirely due to absent safety data. Anyone with bleeding disorders, on immunosuppressants, or uncomfortable with self-injection and its infection risks should reconsider or seek clinical supervision.

NAD+ injections carry all the same cautions as oral NAD+ supplements, plus additional risks related to the injection route.

Anyone with needle anxiety or injection complications history. Self-administered subcutaneous injections carry infection risk if technique or sterility is compromised.

Cardiac arrhythmia or heart conditions. NAD+ affects cardiac electrophysiology. Rapid NAD+ delivery via injection may have different cardiac effects than gradual oral absorption.

Cancer patients. The same theoretical concern about NAD+ fueling cell proliferation applies more acutely with injectable delivery, which produces faster tissue-level concentration spikes.

Anyone on blood thinners. Subcutaneous injections in patients on anticoagulants increase bruising and hematoma risk.

Are NAD+ Injections Worth It?

At 4–15× the cost of oral NMN with zero controlled trials vs 20+ for oral, the evidence-to-cost ratio strongly favors starting with a tested oral precursor unless you have a specific medical reason to bypass oral absorption.

Whether NAD+ injections are worth it depends on how you weigh convenience and bioavailability against cost and evidence. The honest cost-benefit analysis:

The case for: Injections bypass the digestive tract entirely, delivering NAD+ at higher bioavailability than oral precursors. For someone with a specific reason to avoid oral absorption, or who has tried oral precursors without perceived benefit, injections offer a different delivery route.

The case against: At $200–$900 per month versus $30–$60 for oral NMN, injections cost 4–15× more. Oral NMN and NR have 20+ combined randomized controlled trials showing they roughly double blood NAD+ within two weeks. Injections have zero. You are paying a substantial premium for a delivery method that has never been shown, in controlled research, to produce better outcomes than the cheaper oral option. For most people, the evidence-to-cost ratio favors starting oral and reserving injections for a specific, physician-guided reason.

Do NAD+ Injections Help With Weight Loss?

No controlled evidence supports NAD+ injections for weight loss. The metabolic rationale — that NAD+ supports mitochondrial energy use — is theoretical, and no randomized trial has shown fat loss from injectable NAD+. Weight-loss marketing for NAD+ injections runs well ahead of the science.

Some clinics market NAD+ injections for weight loss, but no controlled trial supports this use. The proposed mechanism is indirect: NAD+ supports mitochondrial energy production and sirtuin activity, which are involved in metabolism. In theory, restoring NAD+ could improve metabolic efficiency. In practice, there is no human trial data showing NAD+ injections cause weight loss, and the animal evidence linking NAD+ to metabolic improvement doesn't translate to a proven weight-loss effect in people. If weight management is the goal, NAD+ injections are an expensive intervention with no controlled evidence behind that specific claim.

Why We Recommend Oral Precursors First

We sell an oral NMN supplement, so we have an obvious commercial interest in this recommendation.

We sell an oral NMN supplement, so we have an obvious commercial interest in this recommendation. But the reasoning is straightforward: 12+ published RCTs support oral NMN vs zero for injections, at 5–10% of the cost. If future clinical trials demonstrate clear superiority of injectable NAD+, we'll update this article accordingly. Until then, the evidence favors what we can actually cite.

Where Does Injectable NAD+ Come From?

Injectable NAD+ is prepared by compounding pharmacies under physician prescription — not manufactured to FDA drug standards. Quality depends entirely on the pharmacy's sterile-compounding compliance (USP <797>).

Injectable NAD+ is not an FDA-approved drug. It is prepared as a compounded medication by compounding pharmacies under a physician's prescription. This means the quality, purity, and sterility of injectable NAD+ depend entirely on the compounding pharmacy's standards rather than a standardized manufacturing process.

If you are considering NAD+ injections, the sourcing questions that matter most are whether the compounding pharmacy is licensed and follows USP <797> sterile-compounding standards, whether the preparation is tested for potency and sterility, and whether a licensed provider oversees the prescription. Buying NAD+ injections online without a prescription — which some sites offer — bypasses these safeguards and carries real contamination and dosing risks. The regulatory gray area around injectable NAD+ is exactly why the tested, DSHEA-regulated oral precursors represent a lower-risk starting point for most people.

Our Analysis: NAD+ Injection Cost vs Oral Supplement Cost

We calculated the annual cost comparison between NAD+ injections and oral NMN at standard protocols:

Our analysis: at the standard injection protocol, you'd spend $4,800–$7,200/year on a delivery method with zero published clinical trials, vs $365–$730/year on a method with 12+ trials showing it reliably doubles NAD+. The cost-evidence gap is roughly 10× on both dimensions.

NAD+ Nasal Spray vs Injection

NAD+ nasal spray is a newer delivery format marketed as a needle-free alternative to NAD+ injections. It delivers NAD+ through the nasal mucosa, theoretically offering faster absorption than oral but without the discomfort of injection. However, nasal spray and injections share the same core limitation: neither has published RCTs. Absorption data for intranasal NAD+ is essentially nonexistent in humans, so the claimed bioavailability advantage over oral precursors remains unvalidated. If needle-free delivery is important to you, oral NMN or NR capsules remain the only option with clinical trial backing.

NAD+ Injections for Addiction: What Clinics Claim vs What Evidence Shows

NAD+ therapy for addiction — particularly alcohol and opioid dependence — is one of the most heavily marketed uses of injectable NAD+. Clinics claim it reduces cravings, eases withdrawal, and "resets" brain chemistry. The evidence behind these claims is extremely thin. A 2019 pilot study (Mestayer et al.) measured NAD+ changes in plasma and urine during infusion protocols, but it was uncontrolled and did not establish clinical efficacy. Clinic reports of reduced cravings remain anecdotal, with no controlled trial separating any effect from placebo.

The proposed mechanism is biologically reasonable: addiction disrupts mitochondrial function and depletes NAD+ in reward-pathway neurons. Restoring NAD+ could theoretically support neuronal recovery. But "biologically reasonable" is a low bar — many biologically reasonable interventions fail when actually tested in controlled trials. The honest summary: NAD+ for addiction is a hypothesis being marketed as a treatment. If you or someone you know is struggling with addiction, evidence-based treatments — medication-assisted therapy (MAT), counseling, and structured recovery programs — should be the foundation. NAD+ injections might be explored as an adjunct under medical supervision, but they are not a substitute for proven addiction treatment.

NAD+ Injection Reviews: What Users Actually Report

NAD+ injection reviews across forums, clinic testimonials, and social media follow a consistent pattern: most people report a noticeable energy boost and mental clarity within the first week, with effects described as "subtle but real." Negative reviews focus on injection-site discomfort, cost, and diminishing returns after the initial loading phase.

What complicates interpreting these reviews is the placebo-expectation problem. A person who pays $100+ per injection, seeks it out proactively, and expects improvement is psychologically primed to perceive improvement — a phenomenon well-documented in clinical research. This doesn't mean the effects aren't real; it means you can't attribute them specifically to the NAD+ molecule without a controlled comparison. The reviews that should carry the most weight are those from people who also tried oral precursors, because they can compare the two delivery methods directly. Among those, the most common conclusion is that oral NMN provides similar subjective benefits at a fraction of the cost, though some individuals report stronger effects from injections.

NAD+ Injections at Home: How It Works and What to Consider

NAD+ injections at home are available through telehealth platforms and some compounding pharmacies that ship self-injection kits with a physician prescription. This is legal in most US states but comes with important practical and safety considerations that clinic-administered injections handle for you.

What a home kit typically includes: Vials of compounded NAD+ (usually 100 mg/mL concentration), insulin syringes, alcohol swabs, a sharps container, and dosing instructions. Some services include a virtual consultation with a prescribing provider.

Practical considerations:

• Self-injection technique requires comfort with needles and proper sterile protocol — contamination risk increases outside a clinical setting.
• NAD+ solutions must be refrigerated and used within the timeframe specified by the compounding pharmacy, typically 28 days after reconstitution.
• Dosing is self-managed without real-time medical oversight. If you experience significant flushing, nausea, or chest tightness, there is no clinician present to adjust the rate or respond.
• Cost ranges from $300–$800 per month depending on the telehealth service and dosage, still significantly more expensive than oral NMN ($30–$60/month).

Home NAD+ injections make the most sense for people who have already tried the procedure in a clinical setting, know their tolerance, and want to continue at lower cost than repeated clinic visits. Starting with at-home injections without prior clinical experience is generally not advised.

Who Actually Benefits From NAD+ Injections?

Given the cost, evidence gap, and practical complexity, NAD+ injections occupy a narrow niche. The populations most likely to perceive benefit are those for whom oral absorption is genuinely compromised or inadequate — not the general wellness consumer.

Potentially reasonable candidates:

• People with documented GI absorption issues (Crohn's disease, short bowel syndrome, severe IBS) who cannot reliably absorb oral supplements.
• Individuals who have tried oral NMN or NR at adequate doses for 4–8 weeks without measurable NAD+ elevation (confirmed by blood testing, not subjective feeling).
• Patients under physician care for specific conditions where rapid NAD+ restoration is being explored (e.g., post-acute addiction recovery, under specialist guidance).

Unlikely to benefit over oral:

• Generally healthy adults seeking longevity or energy benefits — oral precursors deliver the same NAD+ elevation with 20+ trials of support.
• Anyone choosing injections primarily because they "seem stronger" — perceived potency and clinical efficacy are different things.
• Cost-sensitive consumers — the 4–15× price premium buys a delivery advantage that has never been shown to produce better outcomes.

NAD+ Injections: What Happens Week by Week?

Week 1 (loading): possible flushing and nausea with early injections; some report energy gains within days. Weeks 2–4: side effects ease, and responders typically notice steadier energy and clarity. Month 2+ (maintenance): the initial 'boost' normalizes into a baseline. No withdrawal effects occur when stopping — NAD+ is not dependency-forming.

Because NAD+ injections lack controlled trial data on outcomes, the following timeline is based on aggregated clinic reports and patient accounts — not clinical evidence. Individual experiences vary widely.

Week 1 (loading phase): Most clinics start with 3 injections in the first week. Commonly reported: mild flushing and nausea with first injection (usually lessens by the second). Some people report energy improvement within 2–3 days; others notice nothing until week 2.

Weeks 2–4: The loading phase typically concludes. Those who will perceive benefit generally report it by now — usually described as steadier energy, improved mental clarity, or better sleep quality. If you notice nothing after 4 weeks, the likelihood of benefit from continued injections is low.

Month 2 onward (maintenance): Maintenance protocols typically drop to 1–2 injections per week. Some users report that the initial "boost" normalizes — the improvement becomes a new baseline rather than a noticeable effect. This is consistent with how NAD+ biology works: once levels stabilize, the dramatic change feeling fades.

Stopping: No withdrawal effects are reported. NAD+ is not addictive or dependency-forming. Levels return to baseline over weeks to months after discontinuation, consistent with the natural half-life of NAD+ metabolic pools.

Frequently Asked Questions

Are NAD+ injections better than oral supplements?

There is no clinical evidence they're better. Injections bypass digestion, which theoretically increases bioavailability, but no trial has compared injection vs oral NAD+ outcomes. Oral NMN and NR have 20+ combined RCTs; injections have zero.

How much do NAD+ injections cost?

$50–$150 per injection. At 1–3 times per week, that's $200–$900/month or $2,400–$10,800/year. Oral NMN costs $30–$60/month for equivalent or better-studied NAD+ elevation.

What are NAD+ injection side effects?

Injection site pain, flushing, nausea, lightheadedness, and occasional cardiac awareness. These are from clinic reports, not controlled trials. The complete risk profile is unknown.

How often should you get NAD+ injections?

Clinic protocols typically recommend 1–3 times per week. These frequencies are not evidence-based. They're derived from clinical practice without controlled trial validation.

Can you do NAD+ injections at home?

Some providers prescribe self-administered subcutaneous NAD+ injections for home use. This requires proper training in injection technique, sterile preparation, and appropriate storage of the compound.

What is the difference between NAD+ injections and NAD+ IV therapy?

Injections are subcutaneous (under the skin) and take minutes. IV therapy delivers NAD+ directly into the bloodstream over 2–4 hours. IV provides faster peak levels; injections are more convenient. Neither has published RCT data. See our NAD+ IV therapy guide.

Where can I get NAD+ injections near me?

NAD+ injections are offered at wellness clinics, functional medicine practices, and some telehealth platforms that ship self-injection kits. Search "NAD+ injections near me" to find local providers. Before booking, verify the clinic uses compounding pharmacy–sourced NAD+ with third-party testing documentation, and confirm a licensed provider reviews your medical history. Note that "near me" availability varies significantly — urban areas typically have multiple providers while rural access may require telehealth options.

Related Reading

• NAD+ supplements: complete guide
• NAD+ IV therapy: costs and evidence
• What is NMN?
• NMN vs NAD: what's the difference?
• NMN side effects
• NMN dosage guide
• Best NMN supplements
• NMN before and after
• Longevity supplements
• NMN and resveratrol

Authoritative Resources

For independent, government-reviewed information on NAD+ and compounded injectables, consult these primary sources:

• NIH Office of Dietary Supplements — Niacin (NAD+ precursor)
• FDA — Drug Compounding: Questions and Answers

Our Batch-Level Purity Testing

Manufactured in a facility operating in compliance with FDA current Good Manufacturing Practices (21 CFR Part 111). Every batch of NMN (Nicotinamide Mononucleotide, 250 mg) undergoes independent third-party testing at an ISO/IEC 17025–accredited laboratory for purity, heavy metals, and microbial contamination. Lot YH-NMN-2025-09 passed every safety threshold.

Analytical methods: heavy metals via ICP-MS; microbiology per USP methods. The data below reflects batch-specific results — not general ingredient claims — verified under current Good Manufacturing Practices (21 CFR Part 111).

Testing performed by ISO/IEC 17025–accredited laboratory. Serving size: 1 capsule (250 mg NMN). Full batch results: yourhealthier.com/pages/lab-results. Original certificates of analysis available upon request.

Testing & Transparency Methodology

Every YourHealthier product referenced here is manufactured in an FDA-registered facility and undergoes independent third-party testing at accredited laboratories (ISO/IEC 17025). Each batch is screened for heavy metals (lead, cadmium, mercury, arsenic) and microbial contamination using validated USP and ICP-MS methods. Batch-specific certificates of analysis are published at yourhealthier.com/pages/lab-results and updated with each new manufacturing run. All testing complies with current Good Manufacturing Practices (21 CFR Part 111). This article is written for general educational purposes and is not medical advice; it has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.

References

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not intended as medical advice.

NAD+ Injections vs Oral Supplements

Metric	Value
NAD+ injection published RCTs	0
Oral NMN published RCTs	12+
Injection cost per shot	$50-$150
Injection monthly cost	$200-$900
Oral NMN monthly cost	$30-$60
Typical injection frequency	1-3x per week
Source: Clinical practice protocols; market survey June 2026

Chart: NAD+ Injections vs Oral — Monthly Cost. Data: Oral NMN $30-60/mo with 12+ RCTs; Oral NR $45-75/mo with 10+ RCTs; Injections $200-900/mo with 0 RCTs.